Complementation of helper-dependent adenoviral vectors: Size effects and titer fluctuations

Journal of Virological Methods

Volumn 68, Issue 2, 1997, Pages 147-159

  Alemany, Ramon ^a   Dai, Yifan ^a   Lou, Yan Chun ^a   Sethi, Erica ^a   Prokopenko, Elena ^a   Josephs, Steven F ^a   Zhang, Wei Wei ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Adenoviral vectors; DNA; Helper dependent

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; FLUORESCENCE MICROSCOPY; GENOME; HELPER VIRUS; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ADENOVIRUS E1 PROTEINS; CELL LINE; GENE DELETION; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HELPER VIRUSES; HUMANS; MUTAGENESIS, INSERTIONAL; PROTEIN SORTING SIGNALS; SERIAL PASSAGE; VIRUS ASSEMBLY; VIRUS REPLICATION;

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

EID: 0030809684     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00129-8     Document Type: Article

References (39)

1. Ahern, K.G., Wang, K., Xu, F., Mathews, C.Z., Pearson, G.D., 1991. Strands hybridize in postreplicative adenovirus overlap recombination. Proc. Natl. Acad. Sci. USA 88, 105-109.
2. Bennett, K., Pearson, G., 1993. Sequence conversion during postreplicative adenovirus overlap recombination. Proc. Natl. Acad. Sci. USA 90, 1397-1401.
3. Bett, A.J., Haddara, W., Prevec, L., Graham, F.L., 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA 91, 8802-8806.
4. Bett, A.J., Prevec, L., Graham, F.L., 1993. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67, 5911-5921.
5. Bloss, T.A., Sugden, B., 1994. Optimal lenghts for DNAs encapsidated by Epstein-Barr virus. J. Virol. 68, 8217-8222.
6. Brough, D.E., Cleghon, V., Klessig, D.F., 1992. Construction, characterization and utilization of cell lines which inducibly express the adenovirus DNA-binding protein. Virology 190, 624-634.
7. Clemens, P.R., Kochanek, S., Sunada, Y., Chan, S., Chen, H.H., Campbell, K.P., Caskey, C.T., 1996. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3, 965-972.
8. Chen, H.H., Mack, L.M., Kelly, R., Ontell, M., Kochanek, S., Clemens, P.R., 1997. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA. 94, 1645-1650.
9. Chen, C., Okayama, H., 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
10. Deuring, R., Klotz, G., Doerfler, W., 1981. An unusual symmetric recombinant adenovirus type 12 DNA and human cell DNA. Proc. Natl. Acad. Sci. USA 78, 3142-3146.
11. Engelhardt, J.F., Ye, X., Doranz, B., Wilson, J.M., 1994. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
12. Fisher, K.J., Choi, H., Burda, J., Chen. S., Wilson, J.M., 1996. Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology 217, 11-22.
13. Ghosh-Choudhury, G., Haj-Ahmad, Y., Graham, F.L., 1987. Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J. 6, 1733-1739.
14. Gluzman. Y., Van Doren, K., 1983. Palindromic adenovirus type 5-simian virus 40 hybrid. J. Virol. 45, 91-103.
15. Gorziglia, M.I., Kadan, M.J., Yei, S., Lim, J., Lee, G.M., Luthra, R., Trapnell, B.C., 1996. Elimination of both E1 and E2A from adenovirus vectors further improves prospects for in vivo human gene therapy. J. Virol. 70, 4173-4178.
16. Grable, M., Hearing, P., 1990. Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J. Virol. 64, 2047-2056.
17. Grable, M., Hearing, P., 1992. cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J. Virol. 66, 723-731.
18. Graham, F.L., 1984. Covalently closed circles of human adenovirus DNA are infectious. EMBO J. 3, 2917-2922.
19. Graham, F.L., Prevec, L., 1991. Manipulation of adenovirus vectors. Methods. Mol. Biol. 7, 109-128.
20. Haecker, S.E., Stedman, H.H., Balice-Gordon, R.J., Smith, D.B.J., Greelish, J.P., Mitchell, M.A., Wells, A., Sweeney, H.L., Wilson, J.M., 1996. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Human Gene Ther. 7, 1907-1914.
21. Hassell, J.A., Lukanidin, E., Fey, G., Sambrook, J., 1978. The structure and expression of two defective adenovirus 2/ simian virus 40 hybrids. J. Mol. Biol. 120, 209-247.
22. Hay, R.T., Stow, N.G., McDougall. I.M., 1984. Replication of adenovirus mini-chromosomes. J. Mol. Biol. 175, 493-510.
23. Hu, C.H., Xu, F.-Y., Wang, K., Pearson, A.N., Pearson, G.D., 1992. Symmetrical adenovirus minichromosomes have hairpin replication intermediates. Gene 110, 145-150.
24. Kochanek, S., Clemens, P.R., Mitani, K., Chen, H., Chan, S., Caskey, C.T., 1996. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA 93, 5731-5736.
25. Krougliak, V., Graham, F.L., 1995. Development of cell lines capable of complementing El, E4, and protein IX defective adenovirus type 5 mutants. Hum. Gene Ther. 6, 1575-1586.
26. Kumar-Sing, R., Chamberlain, J.S., 1996. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Human Mol. Gen. 5, 913-921.
27. Kwong, A.D., Frenkel, N., 1995. Biology of Herpex Simplex Virus (HSV) defective viruses and development of the amplicon system. In: Kaplitt, M.G., Loewy, A.D. (Eds.), Viral Vectors: Gene Therapy and Neuroscience Applications. Academic Press, San Diego.
28. McGrory, W.J., Bautista, D.S., Graham, F.L., 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617.
29. Mitani, K., Graham, F.L., Caskey, C.T., Kochanek, S., 1995. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc. Natl. Acad. Sci. USA 92, 3854-3858.
30. Parks, R.J., Chen, L., Anton, M., Sankar, U., Rudnicki, M.A., Graham, F.L., 1996. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA. 93, 13565-13570.
31. Roux, L., Simon, A.E., Holland, J.J., 1991. Effects of defective interfering particles on virus replication and pathogenesis in vitro and in vivo. Adv. Virus Res. 40, 181-211.
32. Ruben, M., Bachetti, S., Graham, F.L., 1983. Covalently closed circles of adenovirus 5 DNA. Nature 301, 172-174.
33. Schaak, J., Guo, X., Ho, W.Y., Karlok, M., Chen, C., Ornelles, D., 1995. Adenovirus type 5 precursor terminal protein-expressing 293 and HeLa cell lines. J. Virol. 69, 4079-4085.
34. Solnick, D., 1981. Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter. Cell 24, 135-143.
35. Spaete, R.R., Frenkel, N., 1982. The herpes simplex virus amplicon: a new eukaryotic defective virus cloning-amplifying vector. Cell 30, 295-304.
36. Spessot, R., Inchley, K., Hupel, T.M., Bacchetti, S., 1989. Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication. Virology 168, 378-387.
37. Thummel, C., Tjian, R., Grodzicker, T., 1981. Expression of SV40 T antigen under control of adenovirus promoters. Cell 23, 825-836.
38. Yamada, M., Lewis, J.A., Grodzicker, T., 1985. Overproduction of the protein product of a nonselected foreign gene carried by an adenovirus vector. Proc. Natl. Acad. Sci. USA 82, 3567-3571.
39. Yang, Y., Li, Q., Ertl, C.J., Wilson, J.M., 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenovirus. J. Virol. 69, 2004-2015.